MPM BioImpact LLC

Holdings History for Context Therapeutics Inc. - Common Stock (CNTX)

Symbol: CNTX on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 10,679,391 shares
Security Ownership %: 12%

Shares, Excluding Options vs Price

Value, Excluding Options

MPM BioImpact LLC ownership in Context Therapeutics Inc. Common Stock (CNTX)

17 Feb 2026 - MPM BioImpact LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10,679,391 shares of Context Therapeutics Inc. Common Stock (CNTX). This represents 12% ownership of the company. In their previous filing dated 08 Jan 2025, MPM BioImpact LLC had reported owning 14,705,882 shares, indicating a decrease of +27%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
MPM BioImpact LLC	12%	-30%	$15,698,705	10,679,391	-4,026,491	-27%	$1.47	13G/A	31 Dec 2025	17 Feb 2026, 16:09
MPM BioImpact LLC	16%		$14,705,882	14,705,882			$1.00	13G	31 Dec 2024	08 Jan 2025, 16:07

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	1.8%	-0.68%	$15,698,705	10,679,391	-4,026,491	-27%	$1.47	Q4 2025
30 Sep 2025	2.3%	0%	$14,247,058	14,705,882	0		$0.97	Q3 2025
30 Jun 2025	1.7%	0%	$9,635,294	14,705,882	0		$0.66	Q2 2025
31 Mar 2025	1.5%	0%	$9,000,000	14,705,882	0		$0.61	Q1 2025
31 Dec 2024	2.2%	+2.2%	$15,441,176	14,705,882	+14,705,882	NEW	$1.05	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.